Bionano Genomics (BNGO) announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping, including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA software. Other talks covered topics like Bionano’s Ionic system for isolating DNA and RNA for next generation sequencing and advanced analytical tools that could be the future of digital cytogenetics and molecular pathology by enabling digital karyotype construction.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Bionano Genomics announces Bionano Symposium Day 3 highlights
- Bionano Genomics announces Bionano Symposium Day 1 highlights
- Bionano Genomics announces Bionano Symposium 2026
- Bionano Genomics announces publication on OGM, gene editing technology
- Reiterating Buy on Bionano Genomics: Strengthening OGM Adoption and Reimbursement Tailwinds Underpin $7 Price Target